ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,629 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryZurichBEO Therapeutics AG
BEO Therapeutics AG Logo
Verified· 2 sourcesTrust Score
Summary

About the company

BEO Therapeutics AG develops oral microbiome therapies to counteract diseases caused by metabolic waste products, such as gouty arthritis and (cardio-)metabolic disorders. The company focuses on QPS‑designated bacteria to rebalance the gut microbiome and is evaluating BEO 001 in phase 1/2 clinical trials in patients with hyperuricemia.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

BEO Therapeutics AG

✓ Offered2
Oral microbiome therapies
Oral microbiome therapies for the treatment of diseases through metabolic waste products, including gouty arthritis and cardiometabolic conditions; chronic use, rebalancing the gut microbiome and urate metabolism.
Clinical development of BEO 001
Clinical development of BEO 001 with two Phase 1/2 studies in more than 100 patients with hyperuricemia to evaluate safety, mechanism of action and efficacy.
Trust & reputation

ranQ Trust Score of BEO Therapeutics AG: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of October 2026

BEO Therapeutics AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
BEO Therapeutics AG scores 74.8 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.75.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.55.07%
BEO Therapeutics AG scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
BEO Therapeutics AG scores 17.1 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.17.14%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

BEO Therapeutics AG reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once BEO Therapeutics AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

BEO Therapeutics AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank BEO Therapeutics AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of BEO Therapeutics AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Hermetschloostrasse 77
8048 Zurich

At a glance

Legal form
Corporation
UID
CHE-230.398.607
Founded
2019 · 7 years
Last commercial register change
March 17, 2025
Employees
1 to 10
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    SA
    Stallergenes AG
    Dietlikon
    CA
    CUTISS AG
    Schlieren
    ET
    Endogena Therapeutics AG
    Zurich
    MT
    Memo Therapeutics AG
    Schlieren
    VP
    Vifor Pharma Management AG
    Glattbrugg
    VA
    Vaccentis AG
    Zurich
    CA
    Celland AG
    Schlieren
    DT
    Denali Therapeutics CH GmbH
    Zurich